Göran Rådegran
11 – 20 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Association between central haemodynamics and renal function in advanced heart failure : a nationwide study from Sweden
(
- Contribution to journal › Article
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
(
- Contribution to journal › Article
-
Mark
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
(
- Contribution to journal › Article
-
Mark
Bone mineral density in pediatric heart transplanted patients: A retrospective single-centre study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter